ARCHIVES

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

This article is from The Cancer Letter archive.

Vol. 10 No. 10 | March 9, 1984

Download PDF Visit The Full Archive

Related Articles

Nursing Center Moves Onto Campus

May 9, 1986

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Litton Awarded $342,618 For Frederick Fee

February 21, 1975

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

The Number of Adult Cooperative Groups Drops to Four As NSABP, RTOG And GOG Agree to Merge

October 21, 2011

Cancer Control Grows Up Fast As It Moves To Meet Mandate, Take Over Big Part Of NCI Budget

March 15, 1974